ARIAD PHARMACEUTICALS INC Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARIAD PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARIAD PHARMACEUTICALS INC for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Option Exercise | M | 4.49 | 24,036 | 107,922 | 31,422 | |
| Feb 24 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Option Exercise | M | 2.62 | 24,999 | 65,497 | 0 | |
| Feb 24 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Sell | S | 8.00 | 24,036 | 192,288 | 428,232 | 452.3 K to 428.2 K (-5.31 %) |
| Feb 24 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Buy | M | 4.49 | 24,036 | 107,922 | 452,268 | 428.2 K to 452.3 K (+5.61 %) |
| Feb 24 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Sell | S | 8.00 | 24,999 | 199,992 | 428,232 | 453.2 K to 428.2 K (-5.52 %) |
| Feb 24 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Buy | M | 2.62 | 24,999 | 65,497 | 453,231 | 428.2 K to 453.2 K (+5.84 %) |
| Feb 20 2015 | ARIA | ARIAD PHARMACEUTIC ... | DesRosier Thomas | EVP, General Counse ... | Option Exercise | A | 7.34 | 130,000 | 954,200 | 130,000 | |
| Feb 20 2015 | ARIA | ARIAD PHARMACEUTIC ... | DesRosier Thomas | EVP, General Counse ... | Option Exercise | A | 0.00 | 110,000 | 0 | 110,000 | |
| Feb 13 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Buy | P | 6.90 | 12,500 | 86,280 | 1,864,286 | 1.9 M to 1.9 M (+0.68 %) |
| Feb 13 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Buy | P | 6.77 | 12,500 | 84,569 | 1,851,786 | 1.8 M to 1.9 M (+0.68 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Option Exercise | M | 0.00 | 29,334 | 0 | 58,666 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Sell | S | 6.33 | 16,134 | 102,107 | 108,499 | 124.6 K to 108.5 K (-12.95 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Buy | M | 0.00 | 29,334 | 0 | 124,633 | 95.3 K to 124.6 K (+30.78 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | A | 6.45 | 25,000 | 161,250 | 25,000 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 22,665 | 0 | 22,665 | 0 to 22.7 K |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | WILSON WAYNE | Director | Option Exercise | A | 6.45 | 25,000 | 161,250 | 25,000 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | WILSON WAYNE | Director | Grant | A | 0.00 | 12,500 | 0 | 113,000 | 100.5 K to 113 K (+12.44 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | A | 6.45 | 25,000 | 161,250 | 12,500 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 12,500 | 0 | 25,000 | 12.5 K to 25 K (+100.00 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | A | 6.45 | 25,000 | 161,250 | 25,000 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 12,500 | 0 | 109,359 | 96.9 K to 109.4 K (+12.91 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Radaelli Massimo | Director | Option Exercise | A | 6.45 | 25,000 | 161,250 | 25,000 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Radaelli Massimo | Director | Grant | A | 0.00 | 12,500 | 0 | 93,000 | 80.5 K to 93 K (+15.53 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | LAVIDAS ATHANESE | Director | Option Exercise | A | 6.45 | 25,000 | 161,250 | 25,000 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | LAVIDAS ATHANESE | Director | Grant | A | 0.00 | 12,500 | 0 | 119,131 | 106.6 K to 119.1 K (+11.72 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | LAMARCHE JAY R | Director | Option Exercise | A | 6.45 | 25,000 | 161,250 | 25,000 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | LAMARCHE JAY R | Director | Grant | A | 0.00 | 12,500 | 0 | 439,705 | 427.2 K to 439.7 K (+2.93 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Option Exercise | M | 0.00 | 29,334 | 0 | 58,666 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Sell | S | 6.33 | 16,134 | 102,089 | 100,129 | 116.3 K to 100.1 K (-13.88 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Buy | M | 0.00 | 29,334 | 0 | 116,263 | 86.9 K to 116.3 K (+33.74 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Option Exercise | M | 0.00 | 29,334 | 0 | 58,666 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Sell | S | 6.33 | 14,667 | 92,823 | 137,722 | 152.4 K to 137.7 K (-9.62 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Buy | M | 0.00 | 29,334 | 0 | 152,389 | 123.1 K to 152.4 K (+23.84 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Option Exercise | M | 0.00 | 29,334 | 0 | 58,666 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Sell | S | 6.33 | 14,667 | 92,820 | 428,232 | 442.9 K to 428.2 K (-3.31 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Buy | M | 0.00 | 29,334 | 0 | 442,899 | 413.6 K to 442.9 K (+7.09 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 29,334 | 0 | 58,666 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 6.33 | 14,667 | 92,823 | 50,117 | 64.8 K to 50.1 K (-22.64 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 29,334 | 0 | 64,784 | 35.5 K to 64.8 K (+82.75 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Option Exercise | M | 0.00 | 29,334 | 0 | 58,666 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Sell | S | 6.33 | 14,667 | 92,849 | 295,627 | 310.3 K to 295.6 K (-4.73 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Buy | M | 0.00 | 29,334 | 0 | 310,294 | 281 K to 310.3 K (+10.44 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Option Exercise | M | 0.00 | 87,000 | 0 | 174,000 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Buy | M | 0.00 | 87,000 | 0 | 1,250,564 | 1.2 M to 1.3 M (+7.48 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Option Exercise | M | 0.00 | 29,334 | 0 | 58,666 | |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Sell | S | 6.33 | 14,667 | 92,826 | 222,074 | 236.7 K to 222.1 K (-6.20 %) |
| Feb 04 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Buy | M | 0.00 | 29,334 | 0 | 236,741 | 207.4 K to 236.7 K (+14.14 %) |